Invariant LLC
Invariant LLC filed a Q3 report for Bayer Corporation on October 19, 2026, reporting $60,000 in lobbying income.
Lobbying for Bayer Corporation · Agricultural and pharmaceutical company
Educate Members of Congress, staff, and the Administration on pesticide registration and biotech innovation and regulation. Monitor and advise on policy developments pertaining to market oversight and competition matters, and relevant legislative and regulatory efforts. Monitor the Farm Bill reauthorization process, including H.R. 7567, the Farm, Food, and National Security Act of 2026 and S. 5526, the Agricultural Act of 2026, and educate Members on Bayer's priorities.
Educate Members of Congress, staff, and the Administration on the importance of crop protection tools for agricultural purposes.